Early-life respiratory syncytial virus lower respiratory tract infection in a South African birth cohort: epidemiology and effect on lung health

[1]  T. Cherian,et al.  Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting , 2020, Vaccine.

[2]  Mark A. Miller,et al.  Association Between Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection in Early Life and Recurrent Wheeze and Asthma in Later Childhood. , 2019, The Journal of infectious diseases.

[3]  S. Madhi,et al.  Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study , 2019, The Lancet.

[4]  C. Naaktgeboren,et al.  RSV hospitalization in infancy increases the risk of current wheeze at age 6 in late preterm born children without atopic predisposition , 2019, European Journal of Pediatrics.

[5]  O. Ramilo,et al.  The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates. , 2018, The Lancet. Infectious diseases.

[6]  J. Borghans,et al.  Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy. , 2018, Vaccine.

[7]  R. Wood‐Baker,et al.  Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life. , 2018, The Lancet. Respiratory medicine.

[8]  Dan J Stein,et al.  Associations between maternal mental health and early child wheezing in a South African birth cohort , 2018, Pediatric pulmonology.

[9]  M. Rovers,et al.  Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial. , 2018, The Lancet. Respiratory medicine.

[10]  Richard Beasley,et al.  After asthma: redefining airways diseases , 2017, The Lancet.

[11]  H. Zar,et al.  Determining the outcomes of interventions to prevent respiratory syncytial virus disease in children: what to measure? , 2018, The Lancet. Respiratory medicine.

[12]  T. Jartti,et al.  Role of viral infections in the development and exacerbation of asthma in children , 2017, Journal of Allergy and Clinical Immunology.

[13]  M. Lucero,et al.  Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study , 2017, The Lancet.

[14]  L. Bont,et al.  The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood , 2017, Infectious Diseases and Therapy.

[15]  Dan J Stein,et al.  Lung Function in African Infants in the Drakenstein Child Health Study. Impact of Lower Respiratory Tract Illness , 2017, American journal of respiratory and critical care medicine.

[16]  Dan J Stein,et al.  Determinants of early-life lung function in African infants , 2016, Thorax.

[17]  H. Zar,et al.  Aetiology of childhood pneumonia in a well vaccinated South African birth cohort: a nested case-control study of the Drakenstein Child Health Study , 2016, The Lancet Respiratory Medicine.

[18]  K. O'Brien,et al.  Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial. , 2015, The Lancet. Infectious diseases.

[19]  H. Zar,et al.  Incidence of childhood pneumonia: facility-based surveillance estimate compared to measured incidence in a South African birth cohort study , 2015, BMJ Open.

[20]  S. Madhi,et al.  Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta–analysis , 2015, Journal of global health.

[21]  S. Guerra,et al.  Pneumonia in Childhood and Impaired Lung Function in Adults: A Longitudinal Study , 2015, Pediatrics.

[22]  T. Hartert,et al.  Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma. , 2015, American journal of respiratory and critical care medicine.

[23]  Dan J Stein,et al.  Investigating the early-life determinants of illness in Africa: the Drakenstein Child Health Study , 2014, Thorax.

[24]  M. Rovers,et al.  Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. , 2013, The New England journal of medicine.

[25]  R. Lemanske,et al.  The Role of Respiratory Virus Infections in Childhood Asthma Inception , 2010, Immunology and Allergy Clinics of North America.

[26]  H. Bisgaard,et al.  Causal direction between respiratory syncytial virus bronchiolitis and asthma studied in monozygotic twins. , 2010, Chest.

[27]  D. Duffy,et al.  Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. , 2009, American journal of respiratory and critical care medicine.

[28]  David R. Williams,et al.  Social determinants of psychological distress in a nationally-representative sample of South African adults. , 2008, Social science & medicine.

[29]  H. Zar,et al.  Prevalence of symptoms of asthma, rhinitis and eczema in 13‐ to 14‐year‐old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III , 2007, Allergy.

[30]  H. Whittle,et al.  Respiratory illness after severe respiratory syncytial virus disease in infancy in The Gambia. , 1999, The Journal of pediatrics.